Diabetes
Commentary
Goodbye, finger sticks; hello, CGMs
It’s easy to determine whether blood sugar is going up or down and the proportion of time the patient spends in or out of the target glucose range...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
From the Journals
Meta-analysis finds increase in type 1 diabetes incidence, ketoacidosis during COVID pandemic
Data reported in 15 studies showed a 26% increase in DKA incidence during the first year of the pandemic.
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
From the Journals
Spirometry predicts mortality in type 2 diabetes
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
Latest News
Evidence weighed for suicide/self-harm with obesity drugs
“It is not yet clear whether the reported cases are linked to the medicines themselves or to the patients’ underlying conditions or other factors...
Latest News
Link between low co-pays for new diabetes drugs and patient adherence
Low co-pays linked with substantially better 12-month adherence to expensive SGLT2 inhibitors and GLP-1 agonists in U.S. patients with type 2...
News
FDA approves cognitive-behavioral app for adults with type 2 diabetes
The app will be available to patients exclusively by prescription, with a planned 90-day use duration.
Conference Coverage
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
Latest News
Treating obesity: Will new drugs end the crisis?
The drugs offer new hope to millions with obesity complications. But to truly turn the tide on our 42% obesity rate, much more work remains to be...
Latest News
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
“GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis,” but additional studies are needed to confirm the results, the...